|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-5-14
|
|
pubmed:abstractText |
Pemetrexed is a multitargeted antifolate enzyme inhibitor, which has activity against a variety of tumors, including advanced gastric cancer (AGC). The aim of this study was to assess efficacy and safety of pemetrexed plus cisplatin (PemCis) combination in the treatment of AGC in Korean patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0344-5704
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
62
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
263-70
|
|
pubmed:meshHeading |
pubmed-meshheading:17960386-Adenocarcinoma,
pubmed-meshheading:17960386-Adult,
pubmed-meshheading:17960386-Aged,
pubmed-meshheading:17960386-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17960386-Cisplatin,
pubmed-meshheading:17960386-Disease-Free Survival,
pubmed-meshheading:17960386-Female,
pubmed-meshheading:17960386-Glutamates,
pubmed-meshheading:17960386-Guanine,
pubmed-meshheading:17960386-Humans,
pubmed-meshheading:17960386-Infusions, Intravenous,
pubmed-meshheading:17960386-Korea,
pubmed-meshheading:17960386-Male,
pubmed-meshheading:17960386-Middle Aged,
pubmed-meshheading:17960386-Neoplasm Invasiveness,
pubmed-meshheading:17960386-Stomach Neoplasms
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Pemetrexed and cisplatin in patients with advanced gastric cancer: a Korean cancer study group multicenter phase II study.
|
|
pubmed:affiliation |
Department of Internal Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
